Jaguar Health (JAGX) EBITDA Margin Growth (1y) (2016 - 2026)
Jaguar Health (JAGX) EBITDA Margin Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,774.59 Bn | 1,774.53 Bn | - | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 3 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn | 1,552.00 |
| 4 | Vertex Pharmaceuticals | 123.91 Bn | 116.66 Bn | 2.59 Bn | 1,536.00 |
| 5 | Regeneron Pharmaceuticals | 71.79 Bn | 63.04 Bn | 3.31 Bn | -170.00 |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - | - |
| 7 | Argenx Se | 54.75 Bn | 49.57 Bn | 1.41 Bn | 1,049.00 |
| 8 | Alnylam Pharmaceuticals | 38.10 Bn | 35.10 Bn | 959.66 Mn | 1,997.00 |
| 9 | Revolution Medicines | 36.11 Bn | 36.11 Bn | - | - |
| 10 | Jaguar Health | 509,443.80 | -9.55 Mn | 19.11 Mn | 47,575.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 47,575.00 |
| Dec 31, 2025 | -42,417.00 |
| Sep 30, 2025 | -112.00 |
| Jun 30, 2025 | -428.00 |
| Mar 31, 2025 | -7,609.00 |
| Dec 31, 2024 | 9,611.00 |
| Sep 30, 2024 | 7,872.00 |
| Jun 30, 2024 | 4,391.00 |
| Mar 31, 2024 | 2.15 Mn |
| Dec 31, 2023 | 1.93 Mn |
| Sep 30, 2023 | 349.00 |
| Jun 30, 2023 | -8,661.00 |
| Mar 31, 2023 | 3.69 Mn |
| Dec 31, 2022 | -1.91 Mn |
| Sep 30, 2022 | 123,357.00 |
| Jun 30, 2022 | 283,360.00 |
| Mar 31, 2022 | -5.80 Mn |
| Dec 31, 2021 | -31,971.00 |
| Sep 30, 2021 | 3.98 Mn |
| Jun 30, 2021 | 5.73 Mn |